SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Share Buy-Back Programme

21 Mar 2024 07:00

RNS Number : 6892H
Rotork PLC
21 March 2024
 

21 March 2024

 

Rotork plc

Share buy-back programme

 

As announced at the preliminary results on 5 March 2024, Rotork plc ('Rotork' or the 'Company') remains a highly cash generative business with a strong cash position that provides us with considerable financial flexibility. Consistent with our stated capital allocation policy, the Board has decided to return cash to shareholders while retaining a strong balance sheet. As a result, Rotork is commencing a share buyback programme (the 'Programme') to repurchase ordinary shares of 0.5 pence each in the capital of the Company ('Ordinary Shares'). The aggregate purchase price of all Ordinary Shares acquired under the Programme will be no more than £50 million (excluding stamp duty and expenses). Any Ordinary Shares purchased by the Company will be cancelled. Our financial flexibility enables us to pursue strategic investments and we remain active in looking for suitable opportunities, consistent with our Growth+ strategy.

 

The first tranche of the Programme will be carried out through an irrevocable non-discretionary agreement with Morgan Stanley & Co. International Plc ('MS'), pursuant to which MS shall purchase Ordinary Shares as riskless principal (and not as agent of Rotork) for the subsequent sale on to, and purchase by, Rotork. The first tranche of the Programme will run from 21 March 2024 and end no later than 24 May 2024. The aggregate purchase price of all Ordinary Shares acquired under the first tranche of the Programme will be no greater than £10 million (excluding stamp duty and expenses). Any purchases under the Programme will take place in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted at the Company's 2023 Annual General Meeting (the "2023 Authority") and any subsequent authority granted at the Company's next Annual General Meeting on 30 April 2024. The maximum number of Ordinary Shares that the Company is authorised to purchase under the 2023 Authority is 86,082,814 Ordinary Shares. MS will make its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company.

 

Any purchase of Ordinary Shares in relation to the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with (and subject to limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at its 2023 Annual General Meeting (or as subsequently granted at the Company's 2024 AGM), Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). Rotork will announce any market repurchases of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

Enquiries:

 

Nick Hasell/Susanne Yule, FTI Consulting Tel: +44 (0) 3727 1340

Andrew Carter, Investor Relations Director, Rotork Plc Tel: +44 (0) 1225 733 200

 

Legal Entity Identifier: 213800AH5RZIHGWRJ718

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSTVAIIFIS
Date   Source Headline
12th Mar 202510:49 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNS2024 full year results
11th Mar 20257:00 amRNSShare buyback programme
11th Mar 20257:00 amRNSAcquisition of Noah Actuation
7th Mar 20251:35 pmRNSHolding(s) in Company
3rd Mar 20259:02 amRNSTotal Voting Rights
11th Feb 20254:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20259:45 amRNSTotal Voting Rights
13th Jan 20254:18 pmRNSDirector/PDMR Shareholding
2nd Jan 20259:43 amRNSTotal Voting Rights
16th Dec 20243:34 pmRNSDirector/PDMR Shareholding
11th Dec 20244:40 pmRNSDirector/PDMR Shareholding
9th Dec 20241:20 pmRNSCompletion of Share Buyback Programme
6th Dec 20245:43 pmRNSTransaction in Own Shares
5th Dec 20245:15 pmRNSTransaction in Own Shares
4th Dec 20245:19 pmRNSTransaction in Own Shares
3rd Dec 20245:10 pmRNSTransaction in Own Shares
3rd Dec 202411:50 amRNSBoard Committee and Board Role Changes
2nd Dec 20245:12 pmRNSTransaction in Own Shares
2nd Dec 20249:27 amRNSTotal Voting Rights
29th Nov 20245:38 pmRNSTransaction in Own Shares
28th Nov 20245:20 pmRNSTransaction in Own Shares
27th Nov 20245:40 pmRNSTransaction in Own Shares
26th Nov 20245:25 pmRNSTransaction in Own Shares
25th Nov 20245:14 pmRNSTransaction in Own Shares
22nd Nov 20245:17 pmRNSTransaction in Own Shares
21st Nov 20245:04 pmRNSTransaction in Own Shares
20th Nov 20245:09 pmRNSTransaction in Own Shares
20th Nov 202411:00 amRNSDirectorate Change
20th Nov 20247:00 amRNSTrading Update
19th Nov 20245:07 pmRNSTransaction in Own Shares
18th Nov 20245:21 pmRNSTransaction in Own Shares
15th Nov 20245:11 pmRNSTransaction in Own Shares
14th Nov 20245:15 pmRNSTransaction in Own Shares
13th Nov 20245:16 pmRNSTransaction in Own Shares
12th Nov 20245:33 pmRNSTransaction in Own Shares
12th Nov 202412:44 pmRNSDirector/PDMR Shareholding
11th Nov 20245:08 pmRNSTransaction in Own Shares
8th Nov 20245:22 pmRNSTransaction in Own Shares
7th Nov 20245:12 pmRNSTransaction in Own Shares
7th Nov 202412:21 pmRNSShare Buy-Back Programme
1st Nov 20249:17 amRNSTotal Voting Rights
25th Oct 20245:36 pmRNSTransaction in Own Shares
24th Oct 20245:10 pmRNSTransaction in Own Shares
23rd Oct 20245:07 pmRNSTransaction in Own Shares
22nd Oct 20245:09 pmRNSTransaction in Own Shares
21st Oct 20244:53 pmRNSTransaction in Own Shares
18th Oct 20244:54 pmRNSTransaction in Own Shares
17th Oct 20245:07 pmRNSTransaction in Own Shares
16th Oct 20245:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.